Imagion Biosystems has released “Preliminary Report and Appendix 4E for the year ended 31 December 2018.
View Appendix 4E and Preliminary Report.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2